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The transforming growth factors-b1 and b2 (TGF-b)
stimulate synthesis of extracellular matrix proteins
in vitro and appear upregulated in fibrotic conditions, in
scar formation, and in wound healing. The extracellular
matrix in turn might also act as a scavenger or repository
for TGF-b. We therefore studied the in situ distribution
of latent TGF binding protein-1 (LTBP-1) and latent
TGF-b1 on extracellular matrix elements of normal
human skin and skin regenerating from cultured ker-
atinocyte autografts. We localized both LTBP-1 and
latent TGF-b1 to fibrillin-containing (elastic) microfibrils.
Both LTBP-1 and latent TGF-b1 were already present
during the earliest stages of the de novo formation of
Transforming growth factors β (TGF-β), a cytokine familyof three isoforms in mammals, have profound effects oncell growth, morphology, and differentiation (Massague,1990; Sporn and Roberts, 1990; Laiho and Keski-Oja,1992; Miyazono et al, 1993; Rifkin et al, 1993). In
addition, TGF-β stimulate the synthesis of extracellular matrix (ECM)
proteins. Simultaneously, they block ECM degradation by decreasing
the synthesis of matrix metalloproteases and increasing the levels of
protease inhibitors (Border and Ruoslahti, 1992). Thus, TGF-β have
substantial influence on tissue composition, tissue remodelling, and
wound healing. Accordingly, TGF-β appear to be prime effectors in
pathologic conditions such as fibrosis and scar formation during wound
healing (Border and Ruoslahti, 1992; Martin, 1997). It has long been
postulated that the ECM does not only have mechanical functions but
also might act as a scavenger or repository for TGF-β, thus assigning a
new important role to connective tissue. It has been shown in vitro,
that certain ECM proteins such as decorin, fibronectin, thrombo-
spondin, and collagen IV, can bind active TGF-β (reviewed in Taipale
and Keski-Oja, 1997); however, these data still await further
(stoichiometric) corroboration and are currently not supported by
immunohistochemical findings. TGF-β are secreted in latent, inactive
complexes containing two proteins: active TGF-β and its prodomain,
the TGF-β latency-associated protein (LAP or small latent TGF-β1)
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the microfibrillar apparatus, i.e., on fusiform, randomly
oriented microfibrils that later coalesced to form the
typical candelabra-like structures in the papillary dermis.
We show herewith that LTBP-1 exerts a dual role as a
component of fibrillin-microfibrils of the skin and in
targeting latent TGF-b1 to the cutaneous microfibrillar
apparatus. Thus, this major connective tissue structure
does not only serve as a force bearing element and
scaffold for elastin deposition in the dermis, but also as
an important repository for latent TGF-b in the skin.
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(Taipale and Keski-Oja, 1997). Most cell lines, however, secrete TGF-
β as a three-protein-complex (large latent TGF-β) consisting of LAP
associated with high molecular weight proteins, the best characterized
of which are the latent TGF-β binding proteins (LTBP); these bind
to LAP via one or more disulfide bonds. Four LTBP genes have been
isolated so far (LTBP-1 through 4; Kanzaki et al, 1990; More´n et al,
1994; Gibson et al, 1995; Yin et al, 1995; Giltay et al, 1997). LTBP-1
was recently shown to be incorporated into the ECM of fibroblast and
osteoblast cell cultures (Taipale et al, 1992, 1996; Dallas et al, 1995;
Oloffsson et al, 1995). In vivo, LTBP-1 was localized to connective
tissue surrounding gastrointestinal carcinomas (Mizoi et al, 1993), or
endocardial cushion cells of the developing mouse heart (Nakajima
et al, 1997), whereas LTBP-2 was identifed in elastic microfibrils of
bovine ligamentum nuchae (Gibson et al, 1995). Here, we demonstrate
that LTBP-1 is a constituent of fibrillin-containing microfibrils of
normal and regenerating human skin and that the microfibrillar
apparatus of the skin is an important repository for latent TGF-β.
MATERIALS, AND METHODS
Tissue specimens Skin biopies from normal adult volunteers and pediatric
burn patients treated with cultured epithelial autografts (CEA) were used.
The detailed data pertinent to these patients have been reported elsewhere
(Raghunath et al, 1996). CEA sheets were prepared from scalp biopsies by a
commercial laboratory (Biosurface Technology, Boston, MA). For histologic
follow up after grafting, 4 mm punch biopsies were taken under general or
local anesthesia after informed consent of the patients/parents. Biopsies were
obtained 1 wk, 2 wk, 3–4 wk, 1 mo, 2 mo, 4–5 mo, 17 mo, and 24 mo after
transplantation.
Antibodies The mouse monoclonal antibody MoAb69 (kindly provided by
Dr. Robert Glanville, Shriners Hospital for Crippled Children, Portland, OR)
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is specific for the peptic fragment PF3 of fibrillin representing its unique C-
terminus (Maddox et al, 1989); it has no resemblance to regions found in LTBP.
The rabbit anti-serum Ab39 (provided by Dr. Kohei Miyazono, The Cancer
Institute, Tokyo, Japan) was raised against native LTBP-1 purified from human
platelets (Kanzaki et al, 1990; Miyazono et al, 1991); it does not cross-react
with LTBP-2 (More´n et al, 1994). Because LTBP contain protein modules that
are structurally very similar to fibrillins-1 and -2 (reviewed in Saharinen et al,
1996), we performed experiments to exclude cross-reactivity of Ab39 with
fibrillin. Therefore, 2 liters of serum-free Waymouth medium conditioned by
embryonic human dermal fibroblasts were precipitated with 40% saturated
ammonium sulfate. The precipitate was dissolved in 40 ml of 50 mM Tris/
HCl pH 7.4 and extensively dialyzed against several changes of the same buffer
at 4°C. Aliquots were loaded on a 4% sodium dodecyl sulfate-polyacrylamide
gel and proteins were separated under nonreducing conditions and then
transferred for 4–6 h at 495 mV (watts unlimited) onto nitrocellulose membranes
using 25 mM Tris, 192 mM glycine, 0.1% (wt/vol) sodium dodecyl sulfate,
and 20% (vol/vol) methanol. The membranes were blocked with 2% non-fat
dry milk and incubated with MoAb69 1:200 and Ab39 1:400, respectively,
over night at room temperature, washed thoroughly in phosphate-buffered
saline, and incubated with a peroxidase-coupled goat anti-rabbit IgG (Kirkegaard
& Perry, Gaithersburg, MD) 1:2000 or peroxidase-coupled swine anti-mouse
IgG (Dako, Glostrup, Denmark) 1:500 for 2 h at room temperature. Enzyme
reactions were performed with chloronaphthol. In parallel experiments,
fibroblasts were metabolically labeled with 35S-Met/Cys and culture medium
used for radioimmunoprecipitation with Ab39 (Taipale et al, 1994) and MoAb69.
We further used rabbit antibody Ab96 (kindly provided by K. Miyazono) and
goat antibodies against β-LAP (R&D Systems; Minneapolis, MN).
Indirect immunofluorescence microscopy Five micrometer cryostat sec-
tions were fixed in acetone at –20°C for 10 min and air dried. Non-specific
binding sites were blocked for 30 min with phosphate-buffered saline/1%
bovine serum albumin/5% normal swine serum/5% normal goat serum (Dako).
This solution was replaced by polyclonal rabbit anti-sera Ab39 against LTBP-1
and Ab96 against TGF-β1 precursor in dilutions of 1:200. Either antibody was
used in combination with MoAb69 against fibrillin diluted 1:20. These primary
antibodies were detected with biotinylated swine anti-rabbit IgG 1:50 (Dako),
streptavidin-DTAF 1:100 (Jackson Immunoresearch, West Grove, PA), and a
Texas Red coupled goat anti-mouse antibody 1:50 (Jackson Immunoresearch),
respectively. For triple immunofluorescence analyses we used MoAb69 1:20/
donkey anti-mouse antibody-Cy3 1:100 (Jackson Immunoresearch), goat anti-
LAP (1:100)/donkey anti-rabbit-Texas Red 1:100, and Ab39 1:400/swine anti-
rabbit-fluoroscein isothiocyanate 1:30 (Dako). Preparations were mounted in
Mowiol (Hoechst) in Tris/HCl pH 8.6 and examined using a LSM 410 invert
device (Carl Zeiss, Oberkochen, Germany) combined with two HeNe lasers
(543/633 nm) and an argon laser (488 nm) for multicolor fluorescence. In
some instances cryosections of normal human skin were incubated before
immunostaining with 0.1 U human plasmin (Sigma, St. Louis, MO) per ml in
serum-free MEM/HEPES for 1 h at 37°C according to Dallas et al (1995).
Photographs were taken on Tmax 3200 ASA (Kodak), using a Axiophot (Zeiss,
Jena, Germany) epifluorescence equipment.
RESULTS
Ab39 against LTBP-1 does not cross-react with fibrillin The
monoclonal antibody MoAb69 recognizes the carboxyterminus of
fibrillin-1 (Maddox et al, 1989), which is unique to this protein
(Ramirez, 1996). Accordingly, a single band representing fibrillin at
the expected molecular weight of µ320 kDa was obtained under
nonreducing conditions (Fig 1a). No other protein was detected with
this antibody. Ab39, in contrast, did not cross-react with fibrillin, but
specifically recognized a broad band of µ200 kDa (Fig 1). This is in
accordance with published work (Kanzaki et al, 1990; Taipale et al,
1994). In radioimmunoprecipitation, Ab39 precipitated an identical
band (Fig 1b) without any evidence for coprecipitation of fibrillin.
MoAb69 did not work well for immunoprecipitation in our hands
(not shown).
LTBP-1 is present on elastic microfibrils of normal and
regenerating skin In normal skin, LTBP-1 was identified on both
the papillary and the reticular part of the cutaneous microfibrillar
apparatus. This was confirmed by the almost complete colocalization
of LTBP-1 and fibrillin, the major component of the microfibrillar
apparatus (Fig 2a, b). In addition, LTBP-1 was also present in the
walls of some blood vessels and smooth muscle cells of m. arrectores
pilorum where fibrillin was not identified (data not shown). In
regenerating skin, fibrillin and LTBP-1 colocalized extensively to the
Figure 1. Immunoblot and radioimmunoprecipitation analyses exclude
cross-reactivity of Ab39 against LTBP-1 with fibrillin. (a) Immunoblot
from proteins from conditioned fibroblast culture medium separated on a 4%
sodium dodecyl sulfate-polyacrylamide gel under nonreducing conditions and
transferred onto nitrocellulose. Immunodetection of LTBP-1 with Ab39 results
in a broad double band at µ200 kDa (lane 1), whereas MoAb69 recognizes
only fibrillin migrating at µ320 kDa (lane 2). Fibrillin is not recognized by
Ab39 (lane 1) nor is LTBP-1 recognized by Ab39. (b) Ab39 immunoprecipitates
LTPB-1 as a 200 kDa protein from culture medium of metabolically labeled
fibroblasts. There is no coprecipitation of fibrillin. Lane 1, normal rabbit serum;
lane 2, fibronectin; lane 3, LBTP-1; lane 4, crude medium
same ECM structures from which the microfibrillar apparatus was
gradually reconstituted (Raghunath et al, 1996) (Fig 2c–f), starting
from the first fusiform fibrils 7 d after grafting (Fig 2c) to a near
normal appearance 17–24 mo after grafting (Fig 2f).
The TGF-b1 precursor is present on elastic microfibrils The
microfibrillar apparatus of normal skin extensively stained with MoAb69
against fibrillin and Ab96 against β-LAP. Superimposed confocal images
revealed extensive colocalization on individual microfibrillar bundles
(Fig 3a, b). As an example of another force-bearing ECM structure
that is solely composed of microfibrils, we used the suspensory ligament
of the primate (cynomolgus monkey) and the human eye lens. We
found brilliant immunostaining for both fibrillin and TGF-β1 precursor
(Fig 3c). Triple immunofluorescence analyses with a goat antibody
against the TGF-β1 propeptide (LAP) allowed us to localize both
LTBP-1 and latent TGF-β1 to the same individual fibrillin-containing
microfibrils (Fig 3d). In contrast, we could not detect LTBP-1 on
ciliary zonules of the monkey eye lens (Fig 4), which suggests a
different composition of this microfibrillar structure but also that the
antibody Ab39 does not cross-react with fibrillin.
The regenerating microfibrillar apparatus can store latent
TGF-b1 In regenerating skin, TGF-β1 precursor colocalized exten-
sively with the microfibrillar elements throughout the entire process
of the de novo formation of the microfibrillar apparatus (Fig 5). There
were also structures exclusively positive for TGF-β1 precursor and not
for fibrillin, such as some blood vessels (Fig 5e) and m. arrectores
pilorum (Fig 5f). In the epidermis TGF-β1 precursor could be detected
to a varying degree in the cytoplasm of keratinocyte layers with a
predominance in the stratum granulosum (Fig 5c) and occasionally in
basal and suprabasal layers (compare with Fig 3).
Plasmin removes latent TGF-b1 from elastic micro-
fibrils Because the activation of latent TGF-β can be achieved by
proteolytic treatment, we treated normal human skin cryosections with
plasmin. This led to a substantial reduction of the fibrillar staining for
latent TGF-β1 precursor of the microfibrillar apparatus and smooth
muscle (Fig 6b, c). In contrast, fibrillin immunostaining appeared
unchanged and partially slightly enhanced (Fig 6e, f).
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Figure 2. LTBP-1 is a constituent of the microfibrillar apparatus of the
skin. Confocal laser scanning localization of fibrillin and LTBP-1 in normal
and regenerating skin. Each micrograph represents an extended focus view
calculated from 10 section planes (increment 0.360 µm). The yellow mix color
of superimposed images obtained for LTBP-1 (green immunofluorescence)
and fibrillin (red immunofluorescence) suggests in normal skin extensive
colocalization of fibrillin and LTBP-1 on the transpapillary (a) and the
reticular portion of the microfibrillar apparatus (b). Regenerating skin: extensive
colocalization of LTBP-1 with fibrillin throughout all developmental stages of
the microfibrillar apparatus from day 7 after grafting (c), 1 mo after grafting (d),
17 mo after grafting (e), and 2 y after grafting (f). Scale bar: 10 µm.
DISCUSSION
Skin regeneration following transplantation of CEA offers a unique
opportunity to observe the complex processes transforming the initial
arrangement of confluent keratinocyte cultures placed onto a highly
variable, surgically created wound bed into an almost normally struc-
tured skin. This regeneration process includes formation of a neo-
epidermis from CEA, formation of a neodermis from wound bed
connective tissue, and, very importantly, the de novo formation of the
dermo–epidermal junction (Raghunath and Meuli, 1997). We have
recently characterized the morphogenetic stages of the regeneration of
the microfibrillar apparatus in skin regenerating from CEA (Raghunath
et al, 1996). This ECM structure consists of a perpendicular fiber
system traversing the papillary dermis and a horizontal system in the
reticular dermis. Thus, it connects the dermo–epidermal junction with
the deeper dermis. It is a scaffold for elastin deposition and presumably
plays a role in the organization of the papilla/rete ridge pattern
(Raghunath et al, 1996). The main components of 10–12 nm micro-
fibrils have been identified as fibrillins 1 and 2 (reviewed in Ramirez,
1996). These proteins share a number of features with LTPB, including
multiple EGF-like repeats, an RGD sequence, and a novel eight-
Figure 3. Microfibrils of different tissues are a repository for latent
TGF-b1. Confocal laser scanning study of fibrillin and TGF-β1 precursor on
microfibrillar structures in human skin and cynomolgus monkey eye. (a–c)
Tissues were double stained with MoAb69 against fibrillin (red signal) and anti-
β-LAP (green signal). (a, b) The yellow mix color of superimposed images
demonstrates association of TGF-β1 precursor with fibrillin-microfibrils. Note
that the cytoplasm of basal and suprabasal keratinocytes contains latent TGF-
β1. (c) Eye: the picture shows a rod-like ciliary zonule as part of the suspensory
ligament of the eye lens surrounded by parts of the iris and the processus ciliaris.
The yellow mix color demonstrates colocalization of fibrillin and latent TGF-
β1 on the ciliary zonule fiber. (d) Human papillary dermis simultaneously
immunostained for fibrillin (blue signal), LTBP-1 (green signal), and TGF-β1
precursor (red signal). The white mix colors indicates colocalization of all three
antigens on individual microfibrillar bundles. Scale bars: 10 µm.
Figure 4. Fibrillin but not LBTP-1 is present on zonule fibrils of the
cynomolgus monkey eye. Conventional immunofluorescence detection of
fibrillin (a) and LTBP-1 (b) in equatorial cryosection sections of cynomolgus
monkey eye. L, lens; C, lens capsule; ZF, zonule fibril. Fibrillin is present on
zonule fibrils, whereas LTBP-1 cannot be detected. Scale bars: 25 µm.
cyteine repeat motif that is unique to this family of proteins (Saharinen
et al, 1996). Accordingly, it has been suggested that there may be a
gene family of fibrillin-like proteins that are involved in the formation
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Figure 5. The developing microfibrillar apparatus is capable of latent
TGF-b1 storage. Confocal laser scanning localization of fibrillin and TGF-β1
precursor in regenerating skin. Tissues were double stained with MoAb69
against fibrillin (red immunofluorescence) and anti-β-LAP (green immuno-
fluorescence). The yellow mix color of superimposed images demonstrates
association of latent TGF-β1 with fibrillin-microfibrils: (a) 7 d after keratinocyte
grafting; (b) 1 mo after keratinocyte grafting; (c and d) 17 mo after keratinocyte
grafting; (d) represents a high power view of the region designated by the
square in (c). (e) Papillary dermis after 24 mo; (f) deep reticular dermis after
24 mo. There is discordant distribution of both antigens on blood vessels (e)
and m. arrector pili which are positive for latent TGF-β1 only. Scale bar: 10 µm.
of microfibrils and that have important structural roles in maintaining
tissue integrity and organization (Dallas et al, 1995). In accordance
with this hypothesis we found that LTBP-1 is a constitutive element
of the cutaneous microfibrillar apparatus during its entire regeneration
process. This extends earlier reports on the colocalization of LTBP-1
with ECM fibrils deposited in culture, such as bone cells (Dallas et al,
1995), human fibroblasts (Taipale et al, 1996), or endocardial cushion
(Nakajima et al, 1997). The LTBP-1 carrying ECM fibrils in cell
culture were partially characterized by immunoelectron microscopy as
fibronectin fibrils (Taipale et al, 1996). Using monoclonal antibodies
to fibronectin and fibrillin we could confirm in hyperconfluent
fibroblast cultures colocalization of LTBP-1 with the pericellular
fibronectin matrix, but also with fibrillin-containing microfibrils that
are devoid of fibronectin (unpublished data).
The localization of LTBP-1 to the cutaneous microfibrillar apparatus
clearly points to its role in storing latent TGF-β in this ECM
compartment (Fig 7). We have demonstrated this role by showing
that, like LTBP-1, latent TGF-β1 was consistently associated with the
cutaneous microfibrils of the normal and the regenerating microfibrillar
apparatus. Remarkably, like LTBP-1, latent TGF-β1 was associated
Figure 6. Plasmin removes b-LAP from cutaneous microfibrils.
Cryosections of normal human skin were immunostained for TGF-β1 precursor.
(a) Untreated epidermis and papillary dermis; (c) untreated reticular dermis and
a m. arrector pili; (b) cryosections treated with 0.1 U plasmin per ml for 1 h
prior to immunostaining; (d) comparable region of the reticular dermis after
plasmin treatment; (e, f) fibrillin staining confirms absence of conspicuous
damage to the microfibrillar apparatus by plasmin. Scale bars: 50 µm.
with fibrillin-microfibrils as soon as they were discernible during the
regeneration of the microfibrillar apparatus. This graphically demon-
strates that even very small aggregates of fibrillin-microfibrils can
store latent TGF-β1 via LTBP-1 without being a part of a large
supramolecular structure yet. This would allow for storage of latent
TGF-β also during embryogenesis. We could detect latent TGF-β1,
but not LTBP-1, in ciliary zonules of the eye lens, structures that are
solely composed of fibrillin-containing microfibrils. This does not
only highlight compositional differences between the microfibrillar
assemblies in different tissues, but also suggests the presence of another
LTBP targeting latent TGF-β to these ECM structures. At this point
we cannot rule out direct interactions between latent TGF-β and
fibrillin itself. Probably, LTBP-1 plays a skin-specific role targeting
latent TGF-β. We also found colocalization of LTPB-1 and latent
TGF-β on tissue structures besides the microfibrillar apparatus such as
smooth muscle cells and keratinocytes (which were negative for
fibrillin). We could not observe LTBP-1 in normal epidermis and only
occasionally in the neoepidermis of regenerating skin. The possible
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Figure 7. Schematic drawing of microfibril-associated latent TGF-b1.
Small latent TGF-β is composed of TGF-β dimer bound noncovalently to its
prodomain dimer (β-LAP). Large latent TGF-β is formed from small latent
TGF-β and LTBP. LTBP associates with β-LAP by a disulfide bond, and to
microfibrils via an unknown mechanism (Nunes et al, 1997). A proteinase-
sensitive hinge in LTBP beween the contact region with the ECM and the
TGF-β binding domains is highlighted. Cleavage at this protease-sensitive
region results in the release of latent TGF-β from microfibrils, whereas the
cleavage of β-LAP results in the generation of active TGF-β (modified from
Saharinen et al, 1996).
role of keratinocytes as a source for LTBP-1 (and thus large latent
TGF-β1 complex) synthesis, however, warrants further investigation.
Latent TGF-β is activated by heat, acid, or alkaline treatment,
binding to thrombospondin, deglycosylation, proteolysis (Taipale and
Keski-Oja, 1997), or irradiation (Barcellos-Hoff et al, 1994). The most
likely physiologic route of activation involves the proteolytic cleavage
of LAP by plasmin or other proteases (Taipale and Keski-Oja, 1997).
It has been recently shown that LTBP complexed to TGF-β can be
released from the ECM of cultured fibroblasts or bone cells, respec-
tively, by plasmin treatment (Taipale et al, 1994; Dallas et al, 1995).
This is in keeping with our findings that latent TGF-β1 is removed
from the microfibrillar apparatus after plasmin treatment. In contrast,
the fibrillin immunostaining pattern was unchanged, if not slightly
enhanced. We also noted no significant reduction of the LTBP-1 signal
after plasmin digest (unpublished) and therefore speculate that Ab39
might preferentially recognize the aminoterminal portion of LTBP-1
that is retained in association with microfibrils following plasmin
treatment.
It has been recently proposed that the sequestration of latent TGF-
β to the ECM in large pools – as we have shown here – is a prerequiste
for the activation by cell surface-associated plasmin (Nunes et al, 1997).1
Following current concepts (Nunes et al, 1997; Taipale and Keski-Oja,
1997) it is conceivable that a migrating or sedentary cell receives local
and repetitive doses of active TGF-β derived from microfibrils upon
focal cell surface proteolysis in conjunction with focal contacts to the
ECM via integrin receptors. It is worth noting that fibrillin-1 facilitates
cell contacts by an RGD sequence that is recognized by αvβ3 integrin
of dermal fibroblasts (Sakamoto et al, 1996).
This study demonstrates that LTBP-1 is a structural ECM protein
involved in the formation of the cutaneous microfibrillar apparatus.
Based on distribution and reasonable sequence homologies, LTBP-1
qualifies as a new member of the fibrillin family of ECM proteins.
Our data also underline the recently proposed dual role of LTBP-1 in
targeting latent TGF-β to the ECM (Dallas et al, 1995). This will
be important with regard to therapeutic effects of irradiation or
phototherapy, and also microfibrillopathies based on fibrillin mutations
such as the Marfan syndrome or the tight skin mouse phenotype
1The role of plasmin has been highlighted by transgenic mice expressing
human apolipoprotein(a). These animals show an inhibited plasminogen
activation and, in turn, a lack of TGF-β activation in the aortic wall. This is
currently believed to underly the proliferation of vascular smooth muscle cells
in the aortic wall heralding arteriosclerosis (Grainger et al, 1994).
(Ramirez, 1996; Kielty et al, 1998). Finally, these findings will be
important for therapeutic approaches to modulate the activation of
latent TGF-β in the quest for anti-scarring agents.
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